Copyright © 2000 by the European Society of Cardiology.
Vascular complications and clinical outcome after coronary angioplasty with platelet IIb/IIIa receptor blockade. Comparison of transradial vs transfemoral arterial access
a Unité de Cardiologie Interventionelle, Clinique Pasteur, Toulouse, France
b Department of Cardiology, The Geelong Hospital, Australia
revised September 13, 1999; accepted September 15, 1999
Abstract
Aims Vascular complications associated with femoral artery access for interventional cardiological procedures may increase morbidity especially in patients receiving anticoagulants, aspirin, ticlopidine and platelet glycoprotein IIb/IIIa receptor inhibitors. The use of radial arterial access has the potential to reduce the incidence of access site bleeding complications. The purpose of this study was to compare outcomes after the radial and femoral approaches in patients treated with the platelet IIb/IIIa inhibitor, abciximab.
Methods and Results One hundred and fifty consecutive patients treated by abciximab underwent angioplasty by the radial or femoral approach in 83 and 67 cases, respectively. Outcome variables were major cardiac events and major access site bleeding at 1-month follow-up. Freedom from major cardiac events at 1-month follow-up occurred in 78 (93·9%) and 63 (94·0%) patients in the radial and femoral groups, respectively (P=0·99). There were no major access site bleeding complications in the radial group, as opposed to five (7·4%) in the femoral group, P=0·04. Postprocedure length of stay, days (3·7±6·0 radial vs 3·7±2·6 femoral, P=0·96) as well as total hospital length of stay (5·0±4·3 radial vs 4·9±3·0 femoral,P =0·72) were similar in both groups.
Conclusion Coronary angioplasty in patients treated by abciximab using the transradial approach is efficacious with fewer major access site complications than with the transfemoral approach.
Key Words: Coronary angioplasty, transradial, complications
f1 Correspondence: Rémi Choussat MD, Unité de Cardiologie Interventionelle, Clinique Pasteur, 45, avenue de Lombez, Toulouse 31076, France.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  F. A. Spencer and P. G. Steg Major bleeding after PCI. Where is our crystal ball? Eur. Heart J., August 2, 2007; 28(16): 1917 - 1919. [Full Text] [PDF]
|
|
|
|
 |
|
 The Society of Thoracic Surgeons Blood Conservatio, V. A. Ferraris, S. P. Ferraris, S. P. Saha, E. A. Hessel II, C. K. Haan, B. D. Royston, C. R. Bridges, R. S.D. Higgins, G. Despotis, et al. Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline Ann. Thorac. Surg., May 1, 2007; 83(5_Supplement): S27 - S86. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. F. Bertrand, R. De Larochelliere, J. Rodes-Cabau, G. Proulx, O. Gleeton, C. Manh Nguyen, J.-P. Dery, G. Barbeau, B. Noel, E. Larose, et al. A Randomized Study Comparing Same-Day Home Discharge and Abciximab Bolus Only to Overnight Hospitalization and Abciximab Bolus and Infusion After Transradial Coronary Stent Implantation Circulation, December 12, 2006; 114(24): 2636 - 2643. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R A. Archbold, N. M Robinson, and R. J Schilling Radial artery access for coronary angiography and percutaneous coronary intervention BMJ, August 21, 2004; 329(7463): 443 - 446. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Agostoni, G. G. L. Biondi-Zoccai, M. L. De Benedictis, S. Rigattieri, M. Turri, M. Anselmi, C. Vassanelli, P. Zardini, Y. Louvard, and M. Hamon Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures: Systematic overview and meta-analysis of randomized trials J. Am. Coll. Cardiol., July 21, 2004; 44(2): 349 - 356. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S C Eccleshall, M Banks, R Carroll, R Jaumdally, D Fraser, and J Nolan Implementation of a diagnostic and interventional transradial programme: resource and organisational implications Heart, May 1, 2003; 89(5): 561 - 562. [Full Text] [PDF]
|
|
|
|
|
|
H. Emanuelsson Stents, antithrombotic agents and vascular complications. Does site of arterial access make a difference? Eur. Heart J., April 2, 2000; 21(8): 607 - 609. [PDF]
|
|